Green MD - Search Results

1

Heterocycle-substituted proline dipeptides as potent VLA-4 antagonists.

Reger TS, Zunic J, Stock N, Wang B, Smith ND, Munoz B, Green MD, Gardner MF, James JP, Chen W, Alves K, Si Q, Treonze KM, Lingham RB, Mumford RA. Reger TS, et al. Among authors: green md. Bioorg Med Chem Lett. 2010 Feb 1;20(3):1173-6. doi: 10.1016/j.bmcl.2009.12.009. Epub 2009 Dec 4. Bioorg Med Chem Lett. 2010. PMID: 20022493

2

Cyclohexenyl- and dehydropiperidinyl-alkynyl pyridines as potent metabotropic glutamate subtype 5 (mGlu5) receptor antagonists.

Chua PC, Nagasawa JY, Bleicher LS, Munoz B, Schweiger EJ, Tehrani L, Anderson JJ, Cramer M, Chung J, Green MD, King CD, Reyes-Manalo G, Cosford ND. Chua PC, et al. Among authors: green md. Bioorg Med Chem Lett. 2005 Oct 15;15(20):4589-93. doi: 10.1016/j.bmcl.2005.06.099. Bioorg Med Chem Lett. 2005. PMID: 16115767

3

Discovery of highly potent, selective, orally bioavailable, metabotropic glutamate subtype 5 (mGlu5) receptor antagonists devoid of cytochrome P450 1A2 inhibitory activity.

Smith ND, Poon SF, Huang D, Green M, King C, Tehrani L, Roppe JR, Chung J, Chapman DP, Cramer M, Cosford ND. Smith ND, et al. Bioorg Med Chem Lett. 2004 Nov 15;14(22):5481-4. doi: 10.1016/j.bmcl.2004.09.018. Bioorg Med Chem Lett. 2004. PMID: 15482908

4

Glucuronidation of carboxylic acid containing compounds by UDP-glucuronosyltransferase isoforms.

Sakaguchi K, Green M, Stock N, Reger TS, Zunic J, King C. Sakaguchi K, et al. Arch Biochem Biophys. 2004 Apr 15;424(2):219-25. doi: 10.1016/j.abb.2004.02.004. Arch Biochem Biophys. 2004. PMID: 15047194

5

In vitro metabolic studies on the selective metabotropic glutamate receptor sub-type 5 (mGluR5) antagonist 3-[(2-methyl-1,3-thiazol-4-yl) ethynyl]-pyridine (MTEP).

Green MD, Yang X, Cramer M, King CD. Green MD, et al. Neurosci Lett. 2006 Jan 2;391(3):91-5. doi: 10.1016/j.neulet.2005.08.032. Epub 2005 Sep 8. Neurosci Lett. 2006. PMID: 16153770

6

Inhibition of human hepatic CYP isoforms by mGluR5 antagonists.

Green MD, Jiang X, King CD. Green MD, et al. Life Sci. 2004 Jul 9;75(8):947-53. doi: 10.1016/j.lfs.2004.02.009. Life Sci. 2004. PMID: 15193955

7

Synthesis, characterization, and first successful monkey imaging studies of metabotropic glutamate receptor subtype 5 (mGluR5) PET radiotracers.

Hamill TG, Krause S, Ryan C, Bonnefous C, Govek S, Seiders TJ, Cosford ND, Roppe J, Kamenecka T, Patel S, Gibson RE, Sanabria S, Riffel K, Eng W, King C, Yang X, Green MD, O'Malley SS, Hargreaves R, Burns HD. Hamill TG, et al. Among authors: green md. Synapse. 2005 Jun 15;56(4):205-16. doi: 10.1002/syn.20147. Synapse. 2005. PMID: 15803497

8

Cloning and characterization of rabbit liver UDP-glucuronosyltransferase cDNAs. Developmental and inducible expression of 4-hydroxybiphenyl UGT2B13.

Tukey RH, Pendurthi UR, Nguyen NT, Green MD, Tephly TR. Tukey RH, et al. Among authors: green md. J Biol Chem. 1993 Jul 15;268(20):15260-6. J Biol Chem. 1993. PMID: 8325897 Free article.

9

UDP-glucuronosyltransferases.

King CD, Rios GR, Green MD, Tephly TR. King CD, et al. Among authors: green md. Curr Drug Metab. 2000 Sep;1(2):143-61. doi: 10.2174/1389200003339171. Curr Drug Metab. 2000. PMID: 11465080 Review.

10

Projected environmental and public health benefits of extended-interval dosing: an analysis of pembrolizumab use in a US national health system.

Bryant AK, Lewy JR, Bressler RD, Chopra Z, Gyori DJ, Bazzell BG, Moeller JA, Jacobson SI, Fendrick AM, Kerr EA, Ramnath N, Green MD, Hofer TP, Vaishnav P, Strohbehn GW. Bryant AK, et al. Among authors: green md. Lancet Oncol. 2024 Jun;25(6):802-810. doi: 10.1016/S1470-2045(24)00200-6. Lancet Oncol. 2024. PMID: 38821085

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

392 results

Search Page